Prevalence of and risk factors for paratuberculosis in purebred beef cattle.

OBJECTIVE: To estimate the prevalence of paratuberculosis in purebred beef cattle in Texas and identify risk factors for seropositivity. DESIGN: Epidemiologic survey. ANIMALS: 4,579 purebred cattle from 115 beef ranches in Texas. PROCEDURE: Blood was collected, and serum was analyzed for antibodies with a commercial ELISA. Fecal samples were collected and frozen at -80 degrees C until results of the ELISA were obtained, and feces from seropositive cattle were submitted for mycobacterial culture. Herd owners completed a survey form on management factors. RESULTS: Results of the ELISA were positive for 137 of the 4,579 (3.0%) cattle, and 50 of the 115 (43.8%) herds had at least 1 seropositive animal. Results of mycobacterial culture were positive for 10 of the 137 (7.3%) seropositive cattle, and 9 of the 50 (18%) seropositive herds had at least 1 animal for which results of mycobacterial culture were positive. Risk factors for seropositivity included water source, use of dairy-type nurse cows, previous clinical signs of paratuberculosis, species of cattle (Bos taurus vs Bos indicus), and location. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that seroprevalence of paratuberculosis among purebred beef cattle in Texas may be greater than seroprevalence among beef cattle in the United States as a whole; however, this difference could be attributable to breed or regional differences in infection rates or interference by cross-reacting organisms. Veterinarians should be aware of risk factors for paratuberculosis as well as the possibility that unexpected serologic results may be found in some herds.

Evaluation of an inactivated Neospora caninum vaccine in beef feedlot steers.

OBJECTIVE: To evaluate effects of vaccination of feedlot steers against bovine neosporosis on weight gain, feed intake and efficiency (feed intake per gain), and carcass characteristics. DESIGN: Longitudinal observational study. ANIMALS: 60 weaned Brangus steers seronegative for Neospora caninum. PROCEDURE: Steers were assigned to age-matched control and treatment groups. Steers in the treatment group received N. caninum vaccine on days 79 and 106, while control steers received 2 placebo injections. For each steer, serologic status for N. caninum was determined on days 0 (weaning), 51, 79, 106, 135, 163, 191, 219, and 247 by use of an ELISA; body weight was determined on the same days and at slaughter (day 259). Daily feed intake per steer was measured from days 79 to 259. RESULTS: Seroconversion occurred in 23 of 30 (76.7%) steers in the vaccinated group. Immediately after vaccination, average daily gain, average daily feed intake, and feed efficiency were significantly greater in the treatment group than in the control group, but these differences did not persist. No differences between groups were found in regard to live weight at slaughter, hot carcass weight, dressing percentage, or quality grade; however, steers in the vaccinated group had significantly lower yield grades than did control steers. CONCLUSIONS AND CLINICAL RELEVANCE: In feedlot steers, use of this vaccine against N. caninum was safe and did not affect overall feedlot performance or meat quality; effects on yield grade require further evaluation.

Repetitive propofol administration in dogs and cats.

A bolus of propofol was administered to 10 dogs (6 mg/kg intravenously [IV]) and 10 cats (10 mg/kg IV) on three consecutive days. The occurrence of apnea, heart and respiratory rates, blood pressure, time to movement, and changes in a complete blood count and biochemical profile were recorded. Apnea was not seen in the dogs but was seen in three cats. Slight increases in the number of Heinz bodies were seen in six cats, but the increases were not considered clinically significant. No apparent cumulative adverse effects were seen from a bolus of bisulfite-containing propofol, administered on three consecutive days.

Immunity in heifers 12 months after vaccination with a multivalent vaccine containing a United States Leptospira borgpetersenii serovar Hardjo isolate.

OBJECTIVE: To evaluate immunity induced by a multivalent vaccine containing a US Leptospira borgpetersenii serovar Hardjo type hardjo bovis (LHB) isolate in heifers challenged 12 months after vaccination. DESIGN: Prospective vaccine challenge study. ANIMALS: 36 one-month old Holstein heifers. PROCEDURES: 18 heifers were vaccinated at 4 and 8 weeks of age with an inactivated vaccine containing Leptospira fractions. Additionally, 18 heifers were vaccinated at the same age with the same vaccine without any Leptospira fractions. All heifers were challenged with a US-origin LHB 12 months following booster vaccination. Urine samples were collected weekly for 8 weeks after challenge, and serum was collected at -1, 28, and 56 days after challenge for serologic testing. At 8 weeks after challenge, all heifers were necropsied, and kidney and reproductive system samples were collected for bacteriologic culture. RESULTS: 4 of 18 vaccinates had positive results of bacteriologic culture of urine samples, but only at 1 time point. All control heifers had positive results of bacteriologic culture of urine samples for at least 5 time points. Vaccinates had negative results of bacteriologic culture of kidney and reproductive system samples following necropsy, whereas all control heifers had positive results of bacteriologic culture of kidney samples and 5 of 18 had positive results of bacteriologic culture of reproductive system samples. CONCLUSIONS AND CLINICAL RELEVANCE: The vaccine administered to calves at 1 month of age prevented leptospire colonization of kidney and reproductive system tissue and significantly reduced urine shedding following challenge 12 months after vaccination. This vaccine provides an opportunity to protect calves at an early age from becoming infected and ultimately from becoming an LHB reservoir.